Patient with open angle glaucoma with 71) of myopia, complains of blurring of vision on administration of pilocarpine. What is the reason for the blurring?
**Question:** Patient with open angle glaucoma with 71% myopia, complains of blurring of vision on administration of pilocarpine. What is the reason for the blurring?
**Core Concept:**
Pilocarpine is a muscarinic acetylcholine receptor agonist, commonly used as an eye drop for the treatment of glaucoma. In open angle glaucoma, the intraocular pressure (IOP) is increased due to impaired outflow of aqueous humor from the eye. Pilocarpine lowers the IOP by increasing the outflow of aqueous humor through the conventional pathway (trabecular meshwork) and the uveoscleral pathway.
**Why the Correct Answer is Right:**
Pilocarpine's effect on the myopic eye is different compared to a non-myopic eye. In a myopic eye, the axial length is elongated, which reduces the efficiency of the conventional pathway. Consequently, pilocarpine's effect on increasing aqueous humor outflow through the conventional pathway (trabecular meshwork) becomes less effective. This results in a decrease in IOP reduction, leading to a higher IOP compared to a non-myopic eye. As the IOP remains high, pilocarpine causes blurring of vision due to the increased stress on the optic nerve and retina, which can lead to optic disc swelling and damage to the photoreceptor cells.
**Why Each Wrong Option is Incorrect:**
A. Pilocarpine's effect on myopic eyes: This option is incorrect as it does not address the reduced efficiency of the conventional pathway due to myopia, which is the main reason for the blurring of vision in this scenario.
B. Blurring caused by pilocarpine: Although pilocarpine does cause blurring, this option doesn't explain the underlying reason for the blurring in a myopic patient taking pilocarpine, which is the focus of the question.
C. Blurring caused by myopia: This option does not address the specific issue of pilocarpine's reduced efficacy in myopic eyes.
D. Blurring caused by increased IOP: While increased IOP can contribute to vision impairment, the question specifically asks for the reason behind the blurring in myopic patients taking pilocarpine, which is not addressed in this option.
**Clinical Pearl:**
In myopic patients, it is essential to consider the reduced efficiency of pilocarpine's effect on the conventional pathway due to myopia when prescribing pilocarpine eye drops for IOP reduction. The increased stress on the optic nerve and retina caused by high IOP can lead to optic disc swelling and damage to photoreceptor cells, resulting in blurring of vision.